Marion Le Grand

Marseille, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Precision neuro-oncology for children: Time to gear up!

Precision neuro-oncology for children: Time to gear up!

Journal: Trends in cancer
Published: April 02, 2026

BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas.

BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas.

Journal: eLife
Published: October 07, 2024

Poly-pharmacology of existing drugs: How to crack the code?

Poly-pharmacology of existing drugs: How to crack the code?

Journal: Cancer letters
Published: November 03, 2023

Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers.

Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers.

Journal: Cell reports. Medicine
Published: April 13, 2023

ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.

ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.

Journal: Cancer research
Published: March 22, 2023

Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms.

Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms.

Journal: EBioMedicine
Published: December 21, 2022

Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer.

Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer.

Journal: Cancers
Published: March 30, 2021

In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor.

In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor.

Journal: Molecular oncology
Published: May 30, 2020

Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation.

Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation.

Journal: Theranostics
Published: November 30, 2019

Targeting Functional Activity of AKT Has Efficacy against Aggressive Neuroblastoma.

Targeting Functional Activity of AKT Has Efficacy against Aggressive Neuroblastoma.

Journal: ACS pharmacology & translational science
Published: October 18, 2019

Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration.

Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration.

Journal: British journal of cancer
Published: August 21, 2019

Graphene Oxide Functional Nanohybrids with Magnetic Nanoparticles for Improved Vectorization of Doxorubicin to Neuroblastoma Cells.

Graphene Oxide Functional Nanohybrids with Magnetic Nanoparticles for Improved Vectorization of Doxorubicin to Neuroblastoma Cells.

Journal: Pharmaceutics
Published: November 27, 2018
Showing 1-12 of 17

Last Updated: 09/26/2026